Results 61 to 70 of about 31,414 (269)

Cardiac manifestations of sarcoidosis

Journal of Education, Health and Sport, 2022
Introduction and purpose: Sarcoidosis is a chronic, multi-system inflammatory disorder of unknown etiology. Due to the varied clinical picture of patients, the diagnosis of the disease is complicated, especially when the heart is affected.The aim of this
Anna Gorajek, Małgorzata Kudan, Karolina Mikut   +2 more
doaj   +1 more source

Fragmented ECG as a risk marker in cardiovascular diseases [PDF]

, 2014
Various noninvasive tests for risk stratification of sudden cardiac death (SCD) were studied, mostly in the context of structural heart disease such as coronary artery disease (CAD), cardiomyopathy and heart failure but have low positive predictive value
Das, Mithilesh K., Jain, Rahul, Singh, Robin, Yamini, Sundermurthy   +3 more
core   +1 more source

Outcomes of cardiac resynchronization therapy (CRT) in cardiac sarcoidosis patients with a range of ejection fractions

ESC Heart Failure
In cardiac sarcoidosis (CS) patients, the benefit of cardiac resynchronization therapy (CRT) remains unclear. We sought to assess the short‐term and long‐term effects of CRT in CS patients with a range of left ventricular (LV) ejection fractions (LVEFs).
Alexander Liu, Raheel Ahmed, M. Dulay, Joseph Okafor, A. Azzu, K. Ramphul, R. Shi, Gerald Ballo, J. Baksi, K. Wechalekar, R. Khattar, Peter Collins, Athol U. Wells, V. Kouranos, Rakesh Sharma   +14 more
semanticscholar   +1 more source

Diagnosis and Therapy of Cardiac Sarcoidosis: A Clinical Perspective

US Cardiology Review, 2019
Cardiac sarcoidosis, either as part of a systemic process or in its isolated form, is an important and increasingly recognized disorder. It is associated with high rates of morbidity and mortality, including sudden cardiac death.
Steven R Sigman
doaj   +1 more source

Co-occurrence of Myocardial Sarcoidosis and Left Ventricular Non-compaction in a Patient with Advanced Heart Failure

Cardiac Failure Review, 2022
A 46-year-old man with systolic heart failure, end-stage renal disease on dialysis, ventricular tachycardia and pulmonary sarcoidosis presented with decompensated heart failure and cardiogenic shock of unknown aetiology.
Anupam A Kumar, Lena E Tran, Aniket S Rali, Alexander Perez, Robert Hoffman, Kelly Schlendorf   +5 more
doaj   +1 more source

Treatment of cardiomyopathy with PAP therapy in a patient with severe obstructive sleep apnea. [PDF]

, 2012
Obstructive sleep apnea is common in patients with heart failure. This case illustrates that treatment with PAP therapy can improve cardiac function in patients with both conditions.
Grewal, MD, Ritu G.
core   +2 more sources

Cardiac Sarcoidosis: A Comprehensive Clinical Review

Reviews in cardiovascular medicine
Sarcoidosis is an inflammatory multisystemic disease of unknown etiology characterized by the formation of non-caseating granulomas. Sarcoidosis can affect any organ, predominantly the lungs, lymphatic system, skin and eyes.
András Vereckei, Z. Besenyi, V. Nagy, Bence Radics, H. Vágó, Z. Jenei, Gábor Katona, R. Sepp   +7 more
semanticscholar   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Isolated cardiac sarcoidosis: a case report

Российский кардиологический журнал
Introduction. Ventricular arrhythmias are a risk factor for sudden cardiac death. Abnormalities of cardiac rhythm and conduction may be the only subjective manifestation of isolated cardiac sarcoidosis, which occurs in 25% of the total number of patients
I. A. Skomkina, V. F. Mordovin, S. V. Triss, I. V. Stepanov, N. I. Ryumshina, M. A. Polyakova, R. E. Batalov, A. Yu. Falkovskaya   +7 more
doaj   +1 more source

Evaluation of Index of Cardiac-Electrophysiological Balance and Electrocardiographic Alternations in Patients with Sarcoidosis

Sakarya Tıp Dergisi, 2021
Objective: Cardiac sarcoidosis (CS) can manifest with different clinical signs and has a poor prognosis, but the heart is rarely affected alone. We aim to evaluate the arrhythmogenic effects of sarcoidosis by using electrocardiography (ECG) in patients
Yakup Alsancak, Celalettin Korkmaz
doaj   +1 more source